1. Home
  2. SNEX vs KRYS Comparison

SNEX vs KRYS Comparison

Compare SNEX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$74.48

Market Cap

9.1B

Sector

Finance

ML Signal

HOLD

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$335.33

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNEX
KRYS
Founded
1924
2015
Country
United States
United States
Employees
5400
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
10.3B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
SNEX
KRYS
Price
$74.48
$335.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$81.33
$297.60
AVG Volume (30 Days)
987.8K
531.0K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
3.74
1.83
Revenue
$132,378,200,000.00
$389,130,000.00
Revenue This Year
N/A
$38.74
Revenue Next Year
$4.17
$32.53
P/E Ratio
$20.02
$178.69
Revenue Growth
32.53
33.94
52 Week Low
$68.00
$130.50
52 Week High
$141.99
$382.54

Technical Indicators

Market Signals
Indicator
SNEX
KRYS
Relative Strength Index (RSI) 24.57 43.97
Support Level $68.97 $246.17
Resistance Level $105.18 $382.33
Average True Range (ATR) 4.35 17.52
MACD -5.07 -5.71
Stochastic Oscillator 10.57 21.50

Price Performance

Historical Comparison
SNEX
KRYS

About SNEX StoneX Group Inc.

StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: